Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LeMaitre Vascular Raises FY2025 GAAP EPS Guidance from $2.07-$2.24 to $2.23-$2.37 vs $2.15 Est; Raises FY2025 Sales Guidance from $242.000M-$249.000M to $248.000M-$254.000M vs $245.469M Est

Author: Benzinga Newsdesk | August 05, 2025 04:23pm
LeMaitre Vascular (NASDAQ:LMAT) raises FY2025 GAAP EPS guidance from $2.07-$2.24 to $2.23-$2.37 vs $2.15 analyst estimate. Raises FY2025 sales outlook from $242.000 million-$249.000 million to $248.000 million-$254.000 million vs $245.469 million estimate.

Posted In: LMAT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist